Essential Partners
MRVI icon

Essential Partners’s Maravai LifeSciences MRVI Stock Holding History

Essential Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$69 Hold
9
– – ﹤0.01% 2737
2026
Q2 		$56 Sell
9
-7
-44% -$30 ﹤0.01% 2787
2026
Q1 		$45 Buy
+16
New +$54 ﹤0.01% 2789

Other funds holding MRVI

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Dynamic Wealth Strategies
Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM

Essential Partners's MRVI Position: Q3 2026 in Review

Essential Partners held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 9 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Essential Partners first reported a position in MRVI in Q1 2026 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Essential Partners held 9 shares of Maravai LifeSciences worth $69 as of Q3 2026.
  • Essential Partners left its Maravai LifeSciences share count unchanged in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2737 holding.
  • Essential Partners first reported a position in Maravai LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.